Sheridan M. Hoy
- Deucravacitinib: First Approval
2022/11/01 by Sheridan M. Hoy · 27 citations
Immunology and Microbiology · Medicine · #Psoriasis: Treatment and Pathogenesis #Cytokine Signaling Pathways and Interactions #IL-33, ST2, and ILC Pathways
- Pimitespib: First Approval
2022/08/20 by Sheridan M. Hoy · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Heat shock proteins research #Colorectal Cancer Treatments and Studies #Cancer, Hypoxia, and Metabolism